• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Rocket Pharmaceuticals, Inc. - Common Stock (NQ:RCKT)

    3.050 -0.090 (-2.87%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,766,990
    Open 3.140
    Bid (Size) 3.040 (50)
    Ask (Size) 3.120 (1)
    Prev. Close 3.140
    Today's Range 3.040 - 3.159
    52wk Range 2.190 - 24.74
    Shares Outstanding 65,837,894
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    RCKT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RCKT
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit

    Performance

    YTD
    -76.0%
    -76.0%
    1 Month
    +17.8%
    +17.8%
    3 Month
    -61.2%
    -61.2%
    6 Month
    -71.5%
    -71.5%
    1 Year
    -87.4%
    -87.4%

    More News

    Read More
    Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RCKT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
    Via Benzinga
    Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
    Via NewMediaWire
    Topics Fraud Lawsuit
    Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Investors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
    Via NewMediaWire
    Topics Fraud Lawsuit
    Investors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT
    From The Rosen Law Firm PA
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
    From Pomerantz LLP
    Via GlobeNewswire
    Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT
    Via NewMediaWire
    Topics Fraud Lawsuit
    Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours
    Via Benzinga
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Shareholders That Lost Money on Rocket Pharmaceuticals, Inc. (RCKT) Should Contact Levi & Korsinsky About Pending Class Action - RCKT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Shareholders That Lost Money on Rocket Pharmaceuticals, Inc. (RCKT) Should Contact Levi & Korsinsky About Pending Class Action - RCKT
    Via NewMediaWire
    Topics Fraud Lawsuit
    Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
    Via NewMediaWire
    Topics Fraud Lawsuit
    Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
    From Rocket Pharmaceuticals, Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
    From Pomerantz LLP
    Via GlobeNewswire
    Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) Seeking Recovery for Investors - Contact Levi & Korsinsky
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) Seeking Recovery for Investors - Contact Levi & Korsinsky
    Via NewMediaWire
    Topics Fraud Lawsuit
    Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
    Via NewMediaWire
    Topics Fraud Lawsuit
    Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
    Via TheNewswire.com
    Topics Fraud Lawsuit

    Frequently Asked Questions

    Is Rocket Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Rocket Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Rocket Pharmaceuticals, Inc. - Common Stock trade on?
    Rocket Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Rocket Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Rocket Pharmaceuticals, Inc. - Common Stock is RCKT on the Nasdaq Stock Market
    What is the current price of Rocket Pharmaceuticals, Inc. - Common Stock?
    The current price of Rocket Pharmaceuticals, Inc. - Common Stock is 3.050
    When was Rocket Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Rocket Pharmaceuticals, Inc. - Common Stock was at 07/31/25 04:00 PM ET
    What is the market capitalization of Rocket Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Rocket Pharmaceuticals, Inc. - Common Stock is 200.81M
    How many shares of Rocket Pharmaceuticals, Inc. - Common Stock are outstanding?
    Rocket Pharmaceuticals, Inc. - Common Stock has 201M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.